One of the key programs of Soha Pharmaceutical Company in the year of ‘Surge in Production through People’s Participation’ includes developing the product portfolio and producing new products with high-efficacy by deploying state-of-the-art technology.
According to the report
issued by Public Relations and International Affairs unit of the Medical Procurement
Organization, Soha Pharmaceutical Company plans to enhance its production and
sales growth compared to previous years in both domestic and international markets.
It also seeks to gain a larger market share in existing and new therapeutic
groups in line with this year's slogan.
Upgrading and
improving production standards and GMP through the collaboration with relevant
experts, developing strategic partnerships with academic-scientific centers and
knowledge-based companies of the private sector, empowering and enhancing human
capital through training, employing specialized and elite individuals, and
collaborative and contractual production with knowledge-based companies without
factories are among the major actions of the company in the new year to
increase product portfolio diversity.
It is worth
mentioning that improving productivity in all aspects, especially production,
involving all personnel in line with realizing this year's slogan, is one of
the company's key plans.